At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Transnasal Thermal Regulating Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transnasal Induction of Normothermia in Febrile Stroke Patients
In Brief
A clinical study evaluating Transnasal Thermal Regulating Device for Stroke, Ischemic and 4 related conditions. Completed, enrolled 30 participants across 3 sites.
Detailed Summary
The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal Thermal Regulating Device in reducing temperature in a population of febrile subjects who meet the inclusion/exclusion criteria.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Ischemic, Stroke Hemorrhagic, Fever, Seizures, Metabolic Encephalopathy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 2017
Enrollment StartJan 2018
Primary CompletionApr 2022
TodayJul 2026
First PostedDec 4, 2017
Enrollment StartJan 16, 2018
Primary CompletionApr 22, 2022
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 8.6 years ago
Interventions
Transnasal Thermal Regulating Devicedevice
Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours